Dr. Fangusaro Leads COG Trial for Brain Tumors Children's physician leading study to replace chemo with a targeted treatment Tuesday, July 14, 2020 Children's physician leading study to replace chemo...
Children’s Healthcare of Atlanta was recently selected as an OUtMATCH clinical trial site to test whether omalizumab, an FDA-approved treatment for asthma, could be effective at protecting patients with multiple food allergies.
A Children’s Healthcare of Atlanta patient has become the youngest patient to date to receive experimental convalescent plasma transfusions to treat the novel coronavirus.
IDG’s Insider Pro and Computerworld recognize Children’s in 2020 rankings
Imlay Innovation Research Grants for 2020 were awarded by the Children’s Healthcare of Atlanta Pediatric Technology Center to Georgia Tech engineers for orthopedics and pulmonology projects.
Therapy inhibits key regulator of brain tumors while activating the immune response
Emory Maintains Top Five Ranking for Research Grants from the NIH More than $53 million in federal funds enable advances to target childhood diseases Tuesday, Feb. 15, 2022 More than $53 million in...
Abatacept Now FDA Approved for Children Undergoing Unrelated Donor BMT Tested and now available at Children’s, abatacept may lessen racial disparities Tuesday, Dec. 21, 2021 Tested and now available...
The trial will utilize the national Pediatric Emergency Care Applied Research Network (PECARN)
IDG’s Insider Pro and Computerworld recognize Children’s in 2021 rankings